|
About Us
About
the Scientist
Mahnaz
Badamchian, Ph.D., the founder and CEO of ChemLife
Cosmeceuticals LLC, worked
as a research professor in the department of Biochemistry and
Molecular Biology at The George Washington University Medical
Center for 23 years. As an internationally recognized expert in
the areas of thymosins, aging, peptide and protein chemistry,
Dr. Badamchian has been an invited speaker in numerous national
and international meetings on aging, immunology, wound healing,
and skin cancer as well as the principal inventor of several
patents in the US, Canada, and Japan.
Dr.
Badamchian is also the winner of the prestigious Kharazmi International
Award for excellence in research as well as the recipient of the
Professional Working Woman of the Year Award. Having received
numerous funding grants from government and pharmaceutical
companies for advanced studies in aging, immunology, and cancer,
Dr. Badamchian has over 60 peer-reviewed publications in
scientific journals and has served as consultant to the Medical
Devices Advisory Committee of the FDA for the past 10 years.
About
the Company
In 1998, Dr. Badamchian founded ChemLife in order to extend
her more than 25 years of research experience in aging,
immunology, and wound healing to the science of skin care. In
doing so, she developed advanced anti-aging peptides and a skin
delivery complex for topical application. Dr. Badamchian is the
discoverer, developer, and sole authentic source for these
therapeutically effective ingredients called Neuropeptides for
use in topical treatments.
In order to focus on her research, Dr. Badamchian has supplied
these anti-aging Neuropeptides in original formulations she
personally crafted to a select few of the top cosmeceutical
companies to market them in their high-end anti-aging skincare
lines. Unfortunately, the retail markups placed on these
products make them out of reach to the ordinary consumer, with
the flagship face product selling for nearly $600 for a month’s
supply.
As a research scientist, Dr. Badamchian truly believes that the
outcome of her work should be available and reasonably
affordable so that everyone can benefit from it—not just the
select few that can accommodate such hefty price tags. Now that
her exclusivity agreements have expired, Dr. Badamchian has
decided to market her own formulations featuring her own novel
Neuropeptides under her own brand in order to avoid retailer
markups and middleman costs. |
|
